Comparison of the In Vitro Susceptibility of Ceftolozane-Tazobactam With the Cumulative Susceptibility Rates of Standard Antibiotic Combinations When Tested Against Pseudomonas aeruginosa From ICU Patients With Bloodstream Infections or Pneumonia

Abstract Background Pseudomonas aeruginosa remains an important cause of hospital-acquired infections in the United States and is frequently multidrug-resistant (MDR). The Infectious Diseases Society of America guidelines recommend empiric combination therapy that includes an antipseudomonal β-lacta...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Open Forum Infectious Diseases 2019-06, Vol.6 (6), p.ofz240-ofz240
Hauptverfasser:	Shortridge, Dee, Pfaller, Michael A, Arends, S J Ryan, Raddatz, Janet, DePestel, Daryl D, Flamm, Robert K
Format:	Artikel
Sprache:	eng
Schlagworte:	Aminoglycosides Bacterial pneumonia Beta lactamases Ciprofloxacin Comparative analysis Drug therapy Health aspects Hospital patients Levofloxacin Major Metronidazole Pharmaceutical industry Pneumonia Pseudomonas aeruginosa Tazobactam Urinary tract infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!